基本信息
周界文 中国科学院上海有机化学研究所
电子邮件: james_chou@sioc.ac.cn
通信地址: 浦东新区碧波路386号创澜湾
个人简介
周界文 (James J. Chou) 1994年毕业与美国密西根大学物理系,1999年美国哈佛大学生物物理学博士,1999-2002,在美国国立卫生研究院做博士后研究。2003-2011,在美国哈佛大学任助理教授,副教授,2012获得终身教授。2022年底全职回国加入中国科学院上海有机化学研究所和生物与化学交叉研究中心。周界文教授长期从事跨膜受体的信号传导机理和病毒与宿主膜融和机制方面的研究,为揭示这些蛋白在跨膜和近膜区域的盲点开发了一系列高分辨率核磁技术,并从中发现了重要的新生物功能与概念。
周界文研究员长期从事跨膜受体的信号传导机理和病毒与宿主膜融和机制方面的研究,为揭示这些蛋白在跨膜和近膜区域的盲点开发了一系列生物化学和生物物理技术,并从中发现了重要的新生物功能与概念。课题组的研究目标是免疫和细胞因子受体在细胞表面的时空组织与其调控下游信号通路的机理。课题组的转化目标包括发现新型免疫治疗调控剂和多特异性药物提送体系。
更多信息可访问实验室网站:https://www.sioc.ac.cn/jameschou
教育背景
1994-09--1999-06 哈佛大学 生物物理学博士1989-09--1993-06 密歇根大学 物理学学士
工作经历
工作简历
2023-01~现在, 中国科学院上海有机化学研究所, 研究员2012-08~2023-12,哈佛大学, 终身正教授2008-05~2012-08,哈佛大学, 副教授2003-01~2008-05,哈佛大学, 助理教授1999-09~2002-12,美国国立卫生研究院, 博士后
出版信息
发表论文
(1) Structural rewiring of IL-7R dimerization by an oncogenic transmembrane mutation can be reversed by rational design, Proc Natl Acad Sci USA, 2026, (2) Electric dipole moment drives the dynamics of the TNFR1 complex I signalosome, Nature, 2026, (3) Repression of RIPK1 kinase by INPP5D inhibits expression of diverse proinflammatory mediators and late-onset Alzheimer's disease risk factors, Immunity, 2026, (4) Specific Interactions between HIV-1 Env Cytoplasmic Tail and Gag Matrix Domain Probed by NMR, Journal of the American Chemical Society, 2025, (5) PACT prevents aberrant activation of PKR by endogenous dsRNA without sequestration, Nature Communications, 2025, (6) A comprehensive proteome structural analysis suggests undiscovered functional domains in ocean archaea, Protein Sci, 2025, (7) Self-Assembled Antibody-Oligonucleotide Conjugates for Targeted Delivery of Complementary Antisense Oligonucleotides, Angew Chem Int Ed Engl, 2024, (8) Structural basis of γ-chain family receptor sharing at the membrane level, Science, 2023, (9) Self-Assembled L-DNA Linkers for Rapid Construction of Multi-Specific Antibody-Drug Conjugates Library, Angewandte Chemie, 2023, (10) Autoinhibitory structure of preligand association state implicates a new strategy to attain effective DR5 receptor activation, Cell Research, 2023, (11) Structure-guided and phage-assisted evolution of a therapeutic anti-EGFR antibody to reverse acquired resistance, Nature Communications, 2022, (12) Structure of the Streptococcus pyogenes NAD+ Glycohydrolase Translocation Domain and Its Essential Role in Toxin Binding to Oropharyngeal Keratinocytes, J Bacteriol, 2022, (13) An amphipathic Bax core dimer forms part of the apoptotic pore wall in the mitochondrial membrane, EMBO J, 2021, (14) NMR Model of the Entire Membrane-Interacting Region of the HIV-1 Fusion Protein and Its Perturbation of Membrane Morphology, Journal of the American Chemical Society, 2021, (15) A Trimeric Hydrophobic Zipper Mediates the Intramembrane Assembly of SARS-CoV-2 Spike, Journal of the American Chemical Society, 2021, (16) Inhibitor Development against p7 Channel in Hepatitis C Virus, Molecules, 2021, (17) The Diversity and Similarity of Transmembrane Trimerization of TNF Receptors, Frontiers in Cell and Developmental Biology, 2020, (18) HIV-1 fusion inhibitors targeting the membrane-proximal external region of Env spikes, Nature Chemical Biology, 2020, (19) Higher-Order Clustering of the Transmembrane Anchor of DR5 Drives Signaling, Cell, 2019,